Winant Leander van Os
Onderzoeker
- Naam
- Dr. W.L. van Os
- Telefoon
- +31 71 527 4234
- w.l.van.os@lic.leidenuniv.nl
Onderzoeker
- Wiskunde en Natuurwetenschappen
- Leiden Institute of Chemistry
- LIC/Chemical Biology
- LIC/CB/Supramolecular & Biomat. Chem.
- Papadopoulou P., Pol R. van der, Hilten N. van, Os W.L. van, Pattipeiluhu R., Arias Alpizar G., Knol R.A., Noteborn W., Moradi M., Joao Ferraz M., Aerts J.M.F.G, Sommerdijk N.A.J.M., Campbell F., Risselada H.J., Sevink G.J.A. & Kros A. (2024), Phase-separated lipid-based nanoparticles: selective behavior at the nano-bio interface, Advanced Materials 36(6): 2310872.
- Os W.L. van, Wielaert L., Alter C., Davidovic D., Sachl R., Kock T., Ugueto Gonzalez U., Arias-Alpizar G., Lozano Vigario F., Knol R.A., Kuster R., Romeijn S., Lopez Mora N., Detampel P., Hof M., Huwyler J. & Kros A. (2024), Lipid conjugate dissociation analysis improves the in vivo understanding of lipid-based nanomedicine, Journal of Controlled Release 371: 85-100.
- Os W.L. van (19 november 2024), Advancing image-based localization of lipid-based nanomedicines for the exploration of targeted drug delivery (Dissertatie. Leiden Institute of Chemistry (LIC), Faculty of Science, Leiden University). Promotor(en): Kros A. & Kasteren S.I. van.
- Leboux RJ.T., Benne N., Os W.A. van, Bussmann J., Kros A., Jiskoot W. & Slütter B.A. (2021), High-affinity antigen association to cationic liposomes via coiled coil-forming peptides induces a strong antigen-specific CD4+ T-cell response, European Journal of Pharmaceutics and Biopharmaceutics 158: 96-105.
- Zhang H., Os W.L. van, Tian X., Zu G., Ribovski L., Bron R., Bussmann J., Kros A., Yong L. & Zuhorn I.S. (2021), Development of curcumin-loaded zein nanoparticles for transport across the blood–brain barrier and inhibition of glioblastoma cell growth, Biomaterials Science 9(21): 7092-7103.
- Mitra S., Turchetto S, Os W.L. van, Wahlberg L.U., Linderoth B., Behbahani H. & Eriksdotter M. (2021), Amyloid-beta peptides and activated astroglia impairs proliferation of nerve growth factor releasing cells in vitro: implication for encapsulated cell biodelivery-mediated AD therapy, Cells 10(11): 2843.